IP Library Patent Application 14461301
Patent Application
App. No. 14/461,301

PYRROLOQUINOLINE QUINONE BASED COMPOSITIONS AND USES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/461,301
Abstract

The present invention provides pharmaceutical and dietary compositions in which pyrroloquinoline quinone (PQQ) and its derivatives are combined with other biologically active compounds to produce a synergistic beneficial effect beyond the effect produced by PQQ or its derivatives alone. The present invention also provides methods for providing various beneficial effects which comprise administering these compositions to a mammalian subject.

Claims (19)

1 . A composition useful for oral administration comprising:

one or more biologically-active forms of pyrroloquinoline quinone or PQQ derivatives;

one or more creatine species selected from the group consisting of creatine, creatine derivatives and creatyl peptides.

2 . The composition of claim 1 further comprising coenzyme Q10 and melatonin.

3 . The composition of claim 2 further comprising:

one or more amino acids;

one or more compounds selected from the group consisting of lipoic acid, ephedrine, caffeine, omega-3 fatty acids (fish oil), butein, piceatannol, fisetin, genistein, hydroxytyrosol, quercetin, isoliquiritigenin, casokinins, lactokinins and lactotripeptides;

one or more nucleic acid compounds selected from the group consisting of nucleotides, oligonucleotides, monophosphate nucleotides, diphosphate nucleotides, triphosphate nucleotides and cyclic derivatives of nucleotides; and

one or more triglycerides.

4 . The composition according to claim 3 , wherein said PQQ and/or its derivative is present in said composition in any amount between about 0.01% to about 10% by weight based on the total weight of said composition, including all percentages and ranges of percentages therebetween.

5 . The composition according to claim 3 further comprising one or more nutritional adjuvant materials including flavoring agents, colorants, viscosity modifiers, preservatives, chelating agents, antioxidants, surface modifiers and other nutritional adjuvant materials.

6 . The composition of claim 3 further comprising an anti-oxidant-containing food selected from the group consisting of cherries, bananas, grapes, rice and cereals, herbs, olive oil, wine, and beer.

7 . The composition of claim 5 further comprising an anti-oxidant-containing food selected from the group consisting of cherries, bananas, grapes, rice and cereals, herbs, olive oil, wine, and beer.

8 . The composition according to claim 3 , wherein the creatine, or creatine derivatives are present in any amount between 0.001% and 20% by weight based on the total weight of said composition.

9 . The composition according to claim 4 further comprising

one or more nutritional adjuvant materials including flavoring agents, colorants, viscosity modifiers, preservatives, chelating agents, antioxidants, surface modifiers and other nutritional adjuvant materials;

an anti-oxidant-containing food selected from the group consisting of cherries, bananas, grapes, rice and cereals, herbs, olive oil, wine, and beer;

wherein the creatine, or creatine derivatives are present in any amount between 0.001% and 20% by weight based on the total weight of said composition.

10 . A method for activating the expression of SIRT genes, ACE genes and/or DAF 16 comprising the step of orally, intra-nasally or intra-ocularly administering a composition according to any one or more of claims 1 - 6 to a mammalian subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2015
From: 4141 HOLDINGS, LLC; OWOC, JACK H
To: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
Reel/Frame 035474/0712 →